HAYWARD, Calif., June 12, 2013 /PRNewswire/ -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today announced that its Board of Directors has elected Mark M. Sieczkarek as its Chairman. Mr. Sieczkarek has been a member of the Board of Directors since July 2006 and has served as lead director since January 2008. He has more than 18 years of leadership experience in the medical device industry and served as President and CEO of Conceptus, Inc. from 2003 to 2011. Mr. Sieczkarek succeeds Stephen J. Fanning, who remains as President and Chief Executive Officer of Solta Medical.
"As part of our regular review of corporate governance and best practices, our Board of Directors has decided to separate the roles of Chairman and CEO," said Linda Graebner, Chairman of the Board's Nominating and Governance Committee. "In electing Mark our Chairman, our shareholders will benefit from his previous public company experience as well as his seven years of service on Solta's Board of Directors. At the same time, we believe that this transition will enable Steve, our President and CEO, to focus on executing the plan to drive growth and returns from the Company's operations."
"From all perspectives, Solta has emerged as a leader in the growing aesthetics industry and our growth requires the Company to evolve in order to maximize the potential for shareholders, customers and employees," said Mr. Sieczkarek. "I deeply appreciate the Board's confidence in electing me their chairman and look forward to working with the rest of the organization to realize the full potential of Solta Medical."
About Solta Medical, Inc.Solta Medical, Inc. is a global leader in the medical aesthetics market providing innovative solutions with proven efficacy and safety backed by over 10 years of clinical study and research. The company offers aesthetic energy devices for skin resurfacing and rejuvenation, acne reduction, body contouring and skin tightening, as well as tools and accessories to optimize the latest liposuction techniques. The Solta Medical portfolio includes the well-known brands Thermage ®, Fraxel ®, Clear + Brilliant ®, Liposonix ®, Isolaz ®, CLARO ®, VASERlipo ™, VASERshape ™, VASERsmooth ™, VentX ®, PowerX ®, TouchView ®, and Origins ™, which collectively make up a comprehensive platform to address a range of aesthetic skin and body issues. More than two and a half million procedures have been performed with Solta Medical's products around the world. Solta Medical is headquartered in Hayward, CA with field teams and regional offices worldwide.SOURCE Solta Medical, Inc.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts